Maintenance of normoglycemia in diabetic mice by subcutaneous xenografts of encapsulated islets.

The goal of islet transplantation in human diabetes is to maintain the islet grafts in the recipients without the use of immunosuppression. One approach is to encapsulate the donor islets in permselective membranes. Hollow fibers fabricated from an acrylic copolymer were used to encapsulate small numbers of rat islets that were immobilized in an alginate hydrogel for transplantation in diabetic mice. The fibers were biocompatible, prevented rejection, and maintained normoglycemia when transplanted intraperitoneally; hyperglycemia returned when the fibers were removed at 60 days. Normoglycemia was also maintained by subcutaneous implants that had an appropriately constructed outer surface on the fibers.

[1]  B. Solomon,et al.  Long-Term Plasma Glucose Normalization in Experimental Diabetic Rats With Macroencapsulated Implants of Benign Human Insulinomas , 1986, Diabetes.

[2]  M L Yarmush,et al.  A Microperifusion System with Environmental Control for Studying Insulin Secretion by Pancreatic Tissue , 1991, Biotechnology progress.

[3]  P. Lacy,et al.  Insulin Independence After Islet Transplantation Into Type I Diabetic Patient , 1990, Diabetes.

[4]  A. Sun,et al.  The Use, in Diabetic Rats and Monkeys, of Artificial Capillary Units Containing Cultured Islets of Langerhans (Artificial Endocrine Pancreas) , 1977, Diabetes.

[5]  P Aebischer,et al.  Brain tissue reaction to permselective polymer capsules. , 1989, Journal of biomedical materials research.

[6]  A. Sun,et al.  Reversal of Diabetes in BB Rats by Transplantation of Encapsulated Pancreatic Islets , 1990, Diabetes.

[7]  F. Lim,et al.  Microencapsulated islets as bioartificial endocrine pancreas. , 1980, Science.

[8]  P. Lacy,et al.  Perifusion of Isolated Rat Islets in Vitro: Participation of the Microtubular System in the Biphasic Release of Insulin , 1972, Diabetes.

[9]  P Aebischer,et al.  Tissue reaction to intraperitoneal polymer implants: species difference and effects of corticoid and doxorubicin. , 1989, Journal of biomedical materials research.

[10]  M J Lysaght,et al.  Artificial pancreas using living beta cells:. effects on glucose homeostasis in diabetic rats. , 1977, Science.

[11]  P. Lacy,et al.  Method for the Isolation of Intact Islets of Langerhans from the Rat Pancreas , 1967, Diabetes.

[12]  E. Ryan,et al.  CONTINUED FUNCTION OF PANCREATIC ISLETS AFTER TRANSPLANTATION IN TYPE I DIABETES , 1989, The Lancet.

[13]  J Dupré,et al.  Transplantation of encapsulated allogeneic islets into diabetic BB/W rats. Effects of immunosuppression. , 1991, Transplantation.

[14]  T. Starzl,et al.  Pancreatic islet transplantation after upper abdominal exeriteration and liver replacement , 1990, The Lancet.

[15]  B A Solomon,et al.  Biohybrid artificial pancreas: long-term implantation studies in diabetic, pancreatectomized dogs. , 1991, Science.

[16]  W. J. Tze,et al.  Implantable artificial endocrine pancreas unit used to restore normoglycaemia in the diabetic rat , 1976, Nature.